Resolution No. 6/11-1 ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES VACCINES FOR CHILDREN PROGRAM VACCINES TO PREVENT MENINGOCOCCAL DISEASE
The purpose of this resolution is to update the eligible groups for meningococcal vaccination to include children aged 9-23 months of age at increased risk of meningococcal disease, to update the intervals for booster doses, and to add information about the meningococcal polysaccharide vaccine back into the VFC resolution.
VFC resolution 10/10-1 is repealed and replaced by the following:
Eligible groups
•Children aged 9 months through 10 years who are at increased risk for meningococcal disease, including
ochildren who have complement deficiencies (e.g., C5-C9, properidin, factor H, or factor D);
ochildren with HIV infection;
otravelers to or residents of countries in which meningococcal disease is hyperendemic or epidemic;
ochildren who are who are part of an outbreak of a vaccine-preventable serogroup.
•Children aged 2 through 10 years who have anatomic or functional asplenia
•All children aged 11 through 18 years
open here please ►
http://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/06-11mening-mcv.pdf
- Enviado mediante la barra Google"
miércoles, 20 de julio de 2011
Suscribirse a:
Enviar comentarios (Atom)



No hay comentarios:
Publicar un comentario